| RS1347860599 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1347868577 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS1347877363 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS1347906047 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1347908694 |
TGM6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1347914291 |
MAK
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Isolated macular dystrophy |
| RS1347958848 |
GUCY1A1
|
Health Risk |
Pathogenic |
Moyamoya disease with early-onset achalasia, Moyamoya disease with early-onset achalasia |
| RS1348011365 |
AUTS2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder due to AUTS2 deficiency, Autism spectrum disorder due to AUTS2 deficiency |
| RS1348031618 |
RPE65
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS1348039836 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1348057473 |
EGLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS1348061804 |
ITGB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS1348062671 |
ITGA7
|
Health Risk |
Likely pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS1348127604 |
COQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1348129244 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1348149236 |
GALNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1348162749 |
HNRNPK
|
Health Risk |
Pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS1348174898 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1348176225 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, ACADM-related disorder |
| RS1348187150 |
BBS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS1348188346 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS1348189028 |
GMPPB
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS1348196809 |
SPINT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital secretory sodium diarrhea 3, Congenital secretory sodium diarrhea 3 |
| RS1348218790 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1348270931 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1348285195 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Nemaline myopathy 2 |
| RS1348290958 |
ASL
|
Health Risk |
Conflicting classifications of pathogenicity |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1348307652 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1348340748 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS1348341976 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brain small vessel disease 1 with or without ocular anomalies, Brain small vessel disease 1 with or without ocular anomalies |
| RS1348362674 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS1348367722 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1348376140 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1348383754 |
DNAH8
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1348398121 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1348401845 |
ITGB3
|
Health Risk |
Pathogenic |
— |
| RS1348407784 |
GEMIN5
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction, Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction |
| RS1348411642 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Inborn genetic diseases |
| RS1348457314 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS1348467293 |
GUCY2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Leber congenital amaurosis 1 |
| RS1348473206 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1348476527 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS1348479617 |
SLC25A36
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS1348488525 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS1348504554 |
HSD17B10
|
Health Risk |
Likely pathogenic |
HSD10 mitochondrial disease, HSD10 mitochondrial disease |
| RS1348505504 |
GIPC3
|
Health Risk |
Likely pathogenic |
Sensorineural hearing loss disorder, Sensorineural hearing loss disorder |
| RS1348578241 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS1348586850 |
RPGRIP1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 6, Cone-rod dystrophy 13 |
| RS1348587218 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1348591614 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1348603148 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1348606984 |
ABCB4
|
Health Risk |
Pathogenic |
— |
| RS1348610360 |
ABCB4
|
Health Risk |
Pathogenic |
Familial intrahepatic cholestasis type 3, Progressive familial intrahepatic cholestasis type 3 |
| RS1348620586 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1348641548 |
POLG
|
Health Risk |
Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1348650457 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1348655194 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1348701377 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS1348704826 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1348713109 |
EIF2AK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1348730180 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Cardiovascular phenotype |
| RS1348741432 |
KCNMA1
|
Health Risk |
Likely pathogenic |
Cerebellar atrophy, developmental delay |
| RS1348742926 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1348745245 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1348813250 |
WDR35
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 7 with or without polydactyly, Cranioectodermal dysplasia 2 |
| RS1348835311 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1348836250 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS1348880848 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1348892740 |
NOTCH1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Adams-Oliver syndrome 5 |
| RS1348913197 |
EMC1
|
Health Risk |
Pathogenic |
— |
| RS1348922417 |
PRR12
|
Health Risk |
Likely pathogenic |
Neuroocular syndrome, Neuroocular syndrome |
| RS1348932780 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1348949389 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1348956744 |
MSH6
|
Health Risk |
Likely pathogenic |
Carcinoma of colon, Hereditary nonpolyposis colorectal neoplasms |
| RS1348957889 |
NDUFA11
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 14 |
| RS1348974766 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1348982172 |
CNGB3
|
Health Risk |
Likely pathogenic |
— |
| RS1348990547 |
TCF12
|
Health Risk |
Likely pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS1349001113 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS1349009265 |
TCF12
|
Health Risk |
Conflicting classifications of pathogenicity |
TCF12-related craniosynostosis, TCF12-related disorder |
| RS1349024125 |
CUX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Global developmental delay with or without impaired intellectual development |
| RS1349031936 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy type B5 |
| RS1349032508 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS1349048226 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1349048266 |
MYH2
|
Health Risk |
Likely pathogenic |
Myopathy, proximal |
| RS1349052942 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS1349064845 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1349083504 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1349089552 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1349103905 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS1349107308 |
SIX3
|
Health Risk |
Likely pathogenic |
— |
| RS1349144376 |
KCNJ11
|
Health Risk |
Pathogenic |
— |
| RS1349155167 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS1349199518 |
KANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1349202366 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, PCCB-related disorder |
| RS1349215930 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1349222819 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS1349223430 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, X-linked |
| RS1349250538 |
FOXP2
|
Health Risk |
Likely pathogenic |
Childhood apraxia of speech, Childhood apraxia of speech |
| RS1349262257 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |